About Alan James Group
We currently market and sell a line of branded nutritional supplements, most of which have been in the market for longer than 10 years, to major discount retailers, drugstores, grocery stores and warehouse clubs in the United States. Our portfolio includes items in multiple segments, including Energy, Memory, Leg Vein Health, and Heart Health. Recognizable brand names include Ginsana®, Ginkoba®, Venastat®, Optiform SAM-e®, Cransana®, and Ginsana Gold Multiplex®. AJG also distributes Kyolic® in the FD&M Channels under an agreement with Wakunaga of America. In addition, we market a line of private label skincare products on an exclusive basis to General Nutrition Centers (GNC).

We maintain an efficient operational infrastructure, in which we leverage strategic relationships with contract manufacturers, logistics companies and technology partners, enabling us to source and distribute products on a competitive basis, and maintain excellent service levels with our customers. We also maintain relationships with key sales brokers, who in conjunction with our sales and support personnel, can effectively manage the product related and promotional initiatives needed to support and grow the business.

We expect to maintain and strengthen our supplement sales through a combination of targeted promotional activities at both the store and consumer levels. Specifically, we use print advertising in selected periodicals that effectively reach our target consumer, to emphasize product attributes and benefits. In addition, by using in store promotional activities, such as temporary price reductions, to coincide with our marketing initiatives, we can further enhance the value proposition offered to our consumers, stimulating both repeat purchase, and attracting new customers into our franchise.

Given the dynamic nature of demand for consumer products, and the continued emphasis on vitamins, minerals, and nutritional supplements in the context of promoting health and well being, we actively seek opportunities to introduce innovative products that have unique attributes and can establish a competitive position in the marketplace. We utilize both our internal product development personnel, in conjunction with key relationships with strategic partners, to source and introduce new products and technologies.

As part of our growth strategy, we also intend to explore alternative consumer channels to introduce new products and to further broaden our product development and brand building efforts. By utilizing additional channels to develop and support new brands, in a cost effective and targeted manner, we believe that we can simultaneously manage a product portfolio with products at various stages of development, to maintain a pipeline of products to market on an ongoing basis.

In August 2006, Interleukin Genetics, Inc. a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market, acquired the Alan James Group. Alan James currently operates as a wholly owned subsidiary of Interleukin.